Neonatal Advanced Practice Provider Pharmacology Conference 10-23-2020
The conference is designed to help NICU Advanced Practice Providers make evidence-based decisions regarding pharmacological therapies and treatment plans for the neonatal patient.
Target Audience
Nurse Practitioner
Physician Assistant
Learning Objectives
- Discuss the changing practice of amino acid dose and timing
- Identify the benefits of increased energy intake
- Review and compare the currently marketed fat emulsion preparations
- Define neonatal abstinence syndrome (NAS) in infants
- Identify non-pharmacologic options for treatment of NAS based on literature
- Differentiate appropriate pharmacologic options for treatment of NAS based on literature
- Review Homeopathic, Herbal and Lifestyle Recommendations for Depression and Anxiety
- Discuss Side effects
- Compare drug interactions
- Understand “Drug Muggers”
- Compare volume of distribution with body composition
- Describe first-order, one-compartment pharmacokinetic
- Discuss toxic Drug levels and Neonatal dosing guidelines
UPMC
Pittsburgh, PA
United States
Sarah M. Moffett, PharmD, BCPS
Mary Beth Pasqualicchio, Pharm.D.
Melinda M. Miller, PharmD, BCPS
Heidi Maria Weinhold, ND Doctor of Naturopathic Medicine
AAPA
ANCC
Available Credit
- 4.00 AAPA Category I CME
- 4.00 Pharmacotherapeutic
- 4.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation